AKT1 and cancer: Upregulation of oncogenic pathways, notably PI3K-AKT and MAPK signaling (Figure 3a), aligns with their established roles in promoting aggressive cancer phenotypes [33,34] and corroborates prior reports of nicotine-induced activation in patient-derived models [13,14].